Prognostic significance of [18F]FDG PET metabolic parameters in adults and children with soft-tissue sarcoma: a meta-analysis
- 27 February 2024
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Imaging
- Vol. 12 (6) , 683-702
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older AdultsJAMA Network Open, 2021
- Metabolic response as assessed by18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeCancer Medicine, 2020
- Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta‐analysisHead & Neck, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Cochrane Handbook for Systematic Reviews of Interventions2019
- Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parametersSkeletal Radiology, 2014
- Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Outcome for adolescent and young adult patients with osteosarcomaCancer, 2012
- Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescentsCancer, 2010
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapyCancer, 2003